一、个人简历
王雨晴，1991年出生，中共党员，校聘教授，硕士研究生导师。2022年毕业于北京航空航天大学，获得生物医学工程专业博士学位。已发表SCI科研论文近20篇，其中以第一作者或通讯作者身份发表9篇SCI论文（影响因子大于10的论文一篇）。是Biomaterials Advances、Biomedical Materials及Bentham Manuscript Processing System等国际知名期刊论文和出版社评审专家。2022年11月以高层次人才引进安徽中医药大学，任职于中西医结合学院。
二、主持或参与科研项目情况：
1. 安徽省高校重点科研项目，项目编号：2023AH050786 , 主持;
2. 校级人才支持计划，项目编号：DT2300001624, 主持;
3. 安徽省自然科学基金面上项目，项目编号：2308085MH307，参与；
4. 国家自然科学基金面上项目，项目编号：32071359，参与。
三、主要研究方向
中医药防治糖尿病并发症
水凝胶微针设计和制备
中药递送
中西医结合应用于神经、血管、骨骼肌再生
四、近5年发表论文：
1. Y Wang, et al. Electrospun Silk Fibroin-Silk Sericin Scaffolds Induced Macrophage Polarization and Vascularization for Volumetric Muscle Loss Injury, J Funct Biomater, 2025, 16(2): 56.
2. C Chang, Q Chen, K Zuo, H Yuan, L Wang, A Jiang, Y Wang*. Yiqi Huoxue Tongluo formula-containing serum attenuates high glucose-induced injury in microglia via MAPK pathways: Network pharmacology-based analysis and biological validation, EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2024, 71: 102403.
3. L Wang, X Wei, Y Wang*. Promoting Angiogenesis Using Immune Cells for Tissue-Engineered Vascular Grafts[J]. Annals of Biomedical Engineering, 2023, 51(4):660-678.
4. Y Wang, et al. Quercetin-based composite hydrogel promotes muscle tissue regeneration through macrophage polarization and oxidative stress attenuation. Composites Part B-Engineering, 2022, 247.
5. Y Wang, et al. Effect of Electrospun Silk Fibroin–Silk Sericin Films on Macrophage Polarization and Vascularization[J]. ACS Biomaterials Science & Engineering, 2020, 6(6):3502-3512.
6. Y Wang, et al. Macrophage Polarization in Response to Biomaterials for Vascularization[J]. Annals of Biomedical Engineering, 2021, 49(9): 1992-2005.
7. H Liu#, Y Wang#, et al. Aligned graphene/silk fibroin conductive fibrous scaffolds for guiding neurite outgrowth in rat spinal cord neurons[J]. Journal of Biomedical Materials Research Part A, 2020,1-12.
8. Y Wang, et al. Double coating of graphene oxide–polypyrrole on silk fibroin scaffolds for neural tissue engineering[J]. Journal of Bioactive and Compatible Polymers, 2020,35(3):216-227.
五、联系方式
E-mail: zlxxwyq@163.com; QQ:892939368
